CEL-SCI CORPORATION (CVM) Debt Components
- 2025-09-30: Long-term Debt and Lease Obligation, CurrentUSD $2.27M; Long-term Debt and Lease ObligationUSD $5.68M; Convertible Notes PayableUSD (m); Debt Instrument, Convertible, Beneficial Conversion FeatureUSD (m).
- 2017-09-30: Long-term Debt and Lease Obligation, CurrentUSD (m); Long-term Debt and Lease ObligationUSD (m); Convertible Notes PayableUSD (m); Debt Instrument, Convertible, Beneficial Conversion FeatureUSD 12 month · $1.11M.
- 2016-09-30: Long-term Debt and Lease Obligation, CurrentUSD (m); Long-term Debt and Lease ObligationUSD (m); Convertible Notes PayableUSD (m); Debt Instrument, Convertible, Beneficial Conversion FeatureUSD 12 month · $0.00.
- 2012-06-30: Long-term Debt and Lease Obligation, CurrentUSD (m); Long-term Debt and Lease ObligationUSD (m); Convertible Notes PayableUSD $0.00; Debt Instrument, Convertible, Beneficial Conversion FeatureUSD (m).
CEL-SCI CORPORATION Debt Components
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Long-term Debt and Lease Obligation, Current USD | Long-term Debt and Lease Obligation USD | Convertible Notes Payable USD | Debt Instrument, Convertible, Beneficial Conversion Feature USD |
|---|---|---|---|---|
| 2025-09-30 | $2.27M | $5.68M | (m) | (m) |
| 2017-09-30 | (m) | (m) | (m) | 12 month · $1.11M |
| 2016-09-30 | (m) | (m) | (m) | 12 month · $0.00 |
| 2012-06-30 | (m) | (m) | $0.00 | (m) |
| 2012-03-31 | (m) | (m) | $0.00 | (m) |
| 2011-12-31 | (m) | (m) | $2.96M | (m) |
| 2011-09-30 | (m) | (m) | $5.00M | (m) |
| 2011-06-30 | (m) | (m) | $4.93M | (m) |
| 2010-09-30 | (m) | (m) | $0.00 | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quince Therapeutics, Inc. (QNCX) | United States | $0.031B | |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |